Vitamin E hydroquinone is an endogenous regulator of ferroptosis via redox control of 15-lipoxygenase
A. Scott Hinman(BioElectronics (United States)), William D. Shrader(BD Biosciences (United States)), Edgar Lee(BioElectronics (United States)), Jeffrey K. Trimmer(BioElectronics (United States)), Amanda Kahn-Kirby(BioElectronics (United States)), Charles R. Holst(BioElectronics (United States)), Joel Bruegger(BioElectronics (United States)), Kevin P. McCusker(BioElectronics (United States)), Virna Kim(BioElectronics (United States)), Gözde Ulas(BioElectronics (United States)), Akiko Amagata(BioElectronics (United States)), Verónica Rodríguez Rivera(BioElectronics (United States)), Dana M. Davis(Dalhousie University), Yuko Kosaka(BioElectronics (United States)), Kevin G. Hoff(California Institute of Technology), Stephanie Malone(BioElectronics (United States)), Joey C. Latham(BioElectronics (United States)), Janet J. Mei(BioElectronics (United States)), Guy Miller(BioElectronics (United States)), Steve James Richards(BioElectronics (United States))
Cited by 186
Related Papers
Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous Proteins
|Science|2010|272
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
|International Immunopharmacology|2018|198
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
|Frontiers in Oncology|2019|141
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
|Clinical Cancer Research|2022|89
The clinical evidence for targeting human myeloid-derived suppressor cells in cancer patients
|Journal of Leukocyte Biology|2017|55